This compound is a protected amino acid derivative featuring a spirocyclic framework. It is primarily used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the preparation of active pharmaceutical ingredients for antiviral therapies.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 1129634-44-1
Guanidine
pharmaceutical intermediate
Ethyl 6,7-difluoro-1-methyl-4-oxo-1,4-dihydro-[1,3]thiazeto[3,2-a]quinoline-3-carboxylate
Intermediate for Prulifloxacin synthesis
2,6-dichloro-5-fluoronicotinamide
Pharmaceutical intermediate
(5-Bromo-2-methylphenyl)(5-(4-fluorophenyl)thiophen-2-yl)methanone
canagliflozin intermediate
Potassium (S)-5-(tert-butoxycarbonyl)-5-azaspiro[2.4]heptane-6-carboxylate
pharmaceutical intermediate
(S)-tert-Butyl 5-azaspiro[2.4]heptan-7-ylcarbamate
Research chemical intermediate
(6S)-5-[(2-methylpropan-2-yl)oxycarbonyl]-5-azaspiro[2.4]heptane-6-carboxylic acid
VEIYKHIPSJIVRK-QMMMGPOBSA-N
CC(C)(C)OC(=O)N1CC2(CC2)C[C@H]1C(=O)O
—